B&L Asset Management LLC bought a new position in Morgan Stanley (NYSE:MS – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 2,775 shares of the financial services provider’s stock, valued at approximately $289,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of MS. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Morgan Stanley by 382.4% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock worth $166,555,000 after purchasing an additional 1,266,600 shares during the last quarter. Fisher Asset Management LLC boosted its position in Morgan Stanley by 2.7% during the 3rd quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock valued at $2,335,495,000 after buying an additional 590,872 shares during the period. Zurich Insurance Group Ltd FI bought a new stake in Morgan Stanley in the 2nd quarter worth $43,850,000. Erste Asset Management GmbH purchased a new position in shares of Morgan Stanley in the third quarter valued at about $46,067,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Morgan Stanley by 4.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,454,177 shares of the financial services provider’s stock valued at $881,263,000 after acquiring an additional 385,780 shares during the last quarter. Institutional investors own 84.19% of the company’s stock.
Insider Buying and Selling at Morgan Stanley
In related news, Director Stephen J. Luczo sold 60,000 shares of the company’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the transaction, the director now directly owns 138,363 shares of the company’s stock, valued at approximately $16,488,718.71. This represents a 30.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.24% of the stock is owned by company insiders.
Morgan Stanley Stock Performance
Morgan Stanley (NYSE:MS – Get Free Report) last released its earnings results on Wednesday, October 16th. The financial services provider reported $1.88 EPS for the quarter, topping the consensus estimate of $1.57 by $0.31. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. The business had revenue of $15.38 billion for the quarter, compared to the consensus estimate of $14.27 billion. Equities research analysts anticipate that Morgan Stanley will post 7.32 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were given a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 2.81%. The ex-dividend date of this dividend was Thursday, October 31st. Morgan Stanley’s dividend payout ratio (DPR) is 56.32%.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on MS shares. Jefferies Financial Group boosted their price target on Morgan Stanley from $120.00 to $135.00 and gave the company a “buy” rating in a report on Thursday, October 17th. Royal Bank of Canada upped their target price on Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a report on Thursday, October 17th. The Goldman Sachs Group lifted their price target on shares of Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. UBS Group upped their price objective on shares of Morgan Stanley from $102.00 to $112.00 and gave the stock a “neutral” rating in a report on Tuesday, October 8th. Finally, Wells Fargo & Company raised shares of Morgan Stanley from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $107.00 to $142.00 in a research note on Friday, November 15th. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $118.00.
Read Our Latest Stock Analysis on MS
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Read More
- Five stocks we like better than Morgan Stanley
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.